US Stock MarketDetailed Quotes

LSTA Lisata Therapeutics

Watchlist
  • 2.950
  • -0.150-4.84%
Close Sep 18 16:00 ET
24.54MMarket Cap-1152P/E (TTM)

Lisata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-19.67%5.52M
-3.55%6.6M
-55.37%25.71M
-7.87%6.03M
-84.19%5.96M
2.31%6.88M
3.38%6.84M
98.28%57.6M
-4.51%6.54M
441.33%37.72M
Selling and administrative expenses
-21.30%2.92M
-8.32%3.36M
-8.25%12.97M
-9.44%3.01M
-35.27%2.58M
6.51%3.71M
9.83%3.67M
23.24%14.14M
18.66%3.33M
40.42%3.99M
-General and administrative expense
-21.30%2.92M
-8.32%3.36M
-8.25%12.97M
-9.44%3.01M
-35.27%2.58M
6.51%3.71M
--3.67M
23.24%14.14M
18.66%3.33M
40.42%3.99M
Research and development costs
-17.74%2.6M
1.95%3.24M
-70.70%12.73M
-6.25%3.01M
-89.98%3.38M
-2.23%3.16M
-3.17%3.18M
147.27%43.46M
-20.56%3.21M
717.65%33.73M
Operating profit
19.67%-5.52M
3.55%-6.6M
55.37%-25.71M
7.87%-6.03M
84.19%-5.96M
-2.31%-6.88M
-3.38%-6.84M
-98.28%-57.6M
4.51%-6.54M
-441.33%-37.72M
Net non-operating interest income expense
Other net income (expense)
-7.53%479K
-38.81%402K
182.94%2.54M
20.00%660K
108.61%703K
451.06%518K
872.94%657K
1,080.26%897K
900.00%550K
721.95%337K
Gain on sale of security
-26.20%493K
-12.09%589K
158.94%2.72M
20.68%671K
111.87%714K
610.64%668K
963.49%670K
596.69%1.05M
1,290.00%556K
721.95%337K
Other non- operating income (expenses)
90.67%-14K
-1,338.46%-187K
-20.00%-186K
-83.33%-11K
---11K
---150K
91.22%-13K
-106.67%-155K
-140.00%-6K
----
Income before tax
20.65%-5.04M
-0.19%-6.2M
59.14%-23.17M
10.43%-5.37M
85.93%-5.26M
4.06%-6.36M
7.73%-6.19M
-95.71%-56.7M
11.83%-5.99M
-439.67%-37.38M
Income tax
0
-798K
6.01%-2.33M
0
0
-2.33M
0
-64.39%-2.48M
0
0
Net income
-25.25%-5.04M
12.70%-5.4M
61.57%-20.84M
10.43%-5.37M
85.93%-5.26M
39.22%-4.03M
-46.40%-6.19M
-97.43%-54.23M
11.83%-5.99M
-439.67%-37.38M
Net income continuous Operations
-25.25%-5.04M
12.70%-5.4M
61.57%-20.84M
10.43%-5.37M
85.93%-5.26M
39.22%-4.03M
-46.40%-6.19M
-97.43%-54.23M
11.83%-5.99M
-439.67%-37.38M
Minority interest income
0
0
0
0
0
0
0
0
0
0
Net income attributable to the parent company
-25.25%-5.04M
12.70%-5.4M
61.57%-20.84M
10.43%-5.37M
85.93%-5.26M
39.22%-4.03M
-46.40%-6.19M
-97.43%-54.23M
11.83%-5.99M
-439.67%-37.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-25.25%-5.04M
12.70%-5.4M
61.57%-20.84M
10.43%-5.37M
85.93%-5.26M
39.22%-4.03M
-46.40%-6.19M
-97.43%-54.23M
11.83%-5.99M
-439.67%-37.38M
Basic earnings per share
-22.00%-0.61
15.58%-0.65
75.36%-2.58
12.95%-0.66
91.75%-0.65
69.51%-0.5
26.67%-0.77
-40.54%-10.47
55.13%-0.7582
-352.87%-7.88
Diluted earnings per share
-22.00%-0.61
15.58%-0.65
75.36%-2.58
12.95%-0.66
91.75%-0.65
69.51%-0.5
26.67%-0.77
-40.54%-10.47
55.13%-0.7582
-352.87%-7.88
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -19.67%5.52M-3.55%6.6M-55.37%25.71M-7.87%6.03M-84.19%5.96M2.31%6.88M3.38%6.84M98.28%57.6M-4.51%6.54M441.33%37.72M
Selling and administrative expenses -21.30%2.92M-8.32%3.36M-8.25%12.97M-9.44%3.01M-35.27%2.58M6.51%3.71M9.83%3.67M23.24%14.14M18.66%3.33M40.42%3.99M
-General and administrative expense -21.30%2.92M-8.32%3.36M-8.25%12.97M-9.44%3.01M-35.27%2.58M6.51%3.71M--3.67M23.24%14.14M18.66%3.33M40.42%3.99M
Research and development costs -17.74%2.6M1.95%3.24M-70.70%12.73M-6.25%3.01M-89.98%3.38M-2.23%3.16M-3.17%3.18M147.27%43.46M-20.56%3.21M717.65%33.73M
Operating profit 19.67%-5.52M3.55%-6.6M55.37%-25.71M7.87%-6.03M84.19%-5.96M-2.31%-6.88M-3.38%-6.84M-98.28%-57.6M4.51%-6.54M-441.33%-37.72M
Net non-operating interest income expense
Other net income (expense) -7.53%479K-38.81%402K182.94%2.54M20.00%660K108.61%703K451.06%518K872.94%657K1,080.26%897K900.00%550K721.95%337K
Gain on sale of security -26.20%493K-12.09%589K158.94%2.72M20.68%671K111.87%714K610.64%668K963.49%670K596.69%1.05M1,290.00%556K721.95%337K
Other non- operating income (expenses) 90.67%-14K-1,338.46%-187K-20.00%-186K-83.33%-11K---11K---150K91.22%-13K-106.67%-155K-140.00%-6K----
Income before tax 20.65%-5.04M-0.19%-6.2M59.14%-23.17M10.43%-5.37M85.93%-5.26M4.06%-6.36M7.73%-6.19M-95.71%-56.7M11.83%-5.99M-439.67%-37.38M
Income tax 0-798K6.01%-2.33M00-2.33M0-64.39%-2.48M00
Net income -25.25%-5.04M12.70%-5.4M61.57%-20.84M10.43%-5.37M85.93%-5.26M39.22%-4.03M-46.40%-6.19M-97.43%-54.23M11.83%-5.99M-439.67%-37.38M
Net income continuous Operations -25.25%-5.04M12.70%-5.4M61.57%-20.84M10.43%-5.37M85.93%-5.26M39.22%-4.03M-46.40%-6.19M-97.43%-54.23M11.83%-5.99M-439.67%-37.38M
Minority interest income 0000000000
Net income attributable to the parent company -25.25%-5.04M12.70%-5.4M61.57%-20.84M10.43%-5.37M85.93%-5.26M39.22%-4.03M-46.40%-6.19M-97.43%-54.23M11.83%-5.99M-439.67%-37.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -25.25%-5.04M12.70%-5.4M61.57%-20.84M10.43%-5.37M85.93%-5.26M39.22%-4.03M-46.40%-6.19M-97.43%-54.23M11.83%-5.99M-439.67%-37.38M
Basic earnings per share -22.00%-0.6115.58%-0.6575.36%-2.5812.95%-0.6691.75%-0.6569.51%-0.526.67%-0.77-40.54%-10.4755.13%-0.7582-352.87%-7.88
Diluted earnings per share -22.00%-0.6115.58%-0.6575.36%-2.5812.95%-0.6691.75%-0.6569.51%-0.526.67%-0.77-40.54%-10.4755.13%-0.7582-352.87%-7.88
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data